Completed PHASE2 INTERVENTIONAL 2-arm NCT01055912

Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

Multicenter, Randomized, Double-Blind, Placebo- Controlled, Parallel Group, Efficacy and Safety Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

Sponsor: CardioKine Inc.

Conditions Congestive Heart Failure

Interventions Lixivaptan Placebo

Updated 8 times since 2017 Last updated: Jun 20, 2011 Started: Jan 31, 2010 Primary completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01055912, this PHASE2 trial focuses on Congestive Heart Failure and remains completed. Sponsored by CardioKine Inc., it has been updated 8 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CardioKine Inc.
Cardiokine Biopharma, LLC

Data source: CardioKine Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Auburn, United States , Aurora, United States , Ayer, United States , Canton, United States , Carmichael, United States , Clearwater, United States , Dallas, United States , Dayton, United States , Duluth, United States and 15 more locations